U.S. flag

An official website of the United States government

NM_001363.5(DKC1):c.62C>T (p.Ser21Leu) AND Dyskeratosis congenita

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Aug 10, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002962035.3

Allele description [Variation Report for NM_001363.5(DKC1):c.62C>T (p.Ser21Leu)]

NM_001363.5(DKC1):c.62C>T (p.Ser21Leu)

Gene:
DKC1:dyskerin pseudouridine synthase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001363.5(DKC1):c.62C>T (p.Ser21Leu)
HGVS:
  • NC_000023.11:g.154764944C>T
  • NG_009780.1:g.7189C>T
  • NM_001142463.3:c.62C>T
  • NM_001288747.2:c.62C>T
  • NM_001363.5:c.62C>TMANE SELECT
  • NP_001135935.1:p.Ser21Leu
  • NP_001275676.1:p.Ser21Leu
  • NP_001354.1:p.Ser21Leu
  • NP_001354.1:p.Ser21Leu
  • LRG_55t1:c.62C>T
  • LRG_55:g.7189C>T
  • LRG_55p1:p.Ser21Leu
  • NC_000023.10:g.153993219C>T
  • NM_001363.3:c.62C>T
  • NR_110021.2:n.164C>T
  • NR_110022.2:n.164C>T
  • NR_110023.2:n.164C>T
Protein change:
S21L
Molecular consequence:
  • NM_001142463.3:c.62C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001288747.2:c.62C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363.5:c.62C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_110021.2:n.164C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_110022.2:n.164C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_110023.2:n.164C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Dyskeratosis congenita
Identifiers:
MONDO: MONDO:0015780; MedGen: C0265965; OMIM: PS127550

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003279703Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 31, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004067207Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Aug 10, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003279703.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 21 of the DKC1 protein (p.Ser21Leu). This variant is present in population databases (rs782389383, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with DKC1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV004067207.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.62C>T (p.S21L) alteration is located in exon 2 (coding exon 2) of the DKC1 gene. This alteration results from a C to T substitution at nucleotide position 62, causing the serine (S) at amino acid position 21 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024